MAM
PCVX icon

Martingale Asset Management’s Vaxcyte PCVX Stock Holding History

Martingale Asset Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.39M Hold
23,992
– – 0.04% 421
2025
Q4 		$1.11M Buy
23,992
+401
+2% +$17.9K 0.03% 453
2025
Q3 		$850K Buy
23,591
+11,452
+94% +$379K 0.02% 519
2025
Q2 		$395K Buy
+12,139
New +$398K 0.01% 657
2024
Q4 		– Sell
-15,605
Closed -$1.78M – 832
2024
Q3 		$1.78M Sell
15,605
-1,664
-10% -$150K 0.04% 342
2024
Q2 		$1.3M Buy
17,269
+1,429
+9% +$97.3K 0.03% 393
2024
Q1 		$1.08M Sell
15,840
-3
-0% -$208 0.02% 452
2023
Q4 		$995K Buy
+15,843
New +$823K 0.02% 449
2022
Q4 		– Sell
-33,513
Closed -$806K – 870
2022
Q3 		$806K Buy
+33,513
New +$850K 0.02% 497

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return